MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on SilverScript Choice (S5601-048)

Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).

Plan type
Stand-alone drug plan (PDP), Kansas
Premium
$88.30/month
Deductible
$615.00
Change plan

2 of 8 Multiple sclerosis drugs are covered on this plan. All 2 require prior authorization.

6 aren't on the formulary, including Kesimpta and dimethyl fumarate.

  • teriflunomide
    generic Aubagio
    Covered · prior auth
    from $83.26
    Tier 5
  • fingolimod
    generic Gilenya
    Covered · prior auth
    $139.98
    Tier 5
Not on the formulary
Kesimpta, dimethyl fumarate, Vumerity, Mayzent, Zeposia, Mavenclad

Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.

Full plan details · This plan's whole drug list